Brief: FDA Approves Dermavant Science's Vtama For Topical Treatment Of Atopic Dermatitis In Adult & Pediatric Patients 2 Years & Older
13/12/2024 19:09
Dec 13 (Reuters) - FDA:
* FDA: APPROVES DERMAVANT SCIENCE'S VTAMA FOR TOPICAL
TREATMENT OF
ATOPIC DERMATITIS IN ADULT & PEDIATRIC PATIENTS 2 YEARS & OLDER
- WEBSITE
Further company coverage: OGN.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Organon & Co.
See all newsIndia's Sun Pharma misses debt fundraise goal as investors demand higher yields, bankers say
Brief: Organon & Co Says It Does Not Expect To Record Milestone Expense In Q3 2026
India's Persistent Systems plans debut rupee debt sale to fund acquisition, bankers say
India's Sun Pharma plans $1 billion local debt sale for loan takeout, sources say
Organon & Co reports results for the quarter ended June 30 - Earnings Summary